NuVasive Announces Upcoming CFO Change, Reports EarningsTuesday, April 29, 2014
NuVasive Inc. said Quentin Blackford will be assuming the role of chief financial officer later this year when Michael Lambert, the current CFO of the San Diego spine implant maker, retires.
Blackford is the company’s current executive vice president of finance, accounting and investor relations.
The news comes on the heels of NuVasive’s (Nasdaq: NUVA) first quarter earnings release, which showed total revenue grew 11.3 percent to $177.5 million for the reporting period ended March 31, 2014, compared with revenue of $159.5 million for the like quarter 2013.
On a GAAP basis, the company reported a net loss of $18.3 million, or 40 cents per share, for the first quarter 2014.
For more earnings information on earnings, click here.
Lambert has been CFO of NuVasive since November 2009, and he’ll retire July 31 this year “for personal and family reasons,” the company said. He plans to stay involved in the company through March 31, 2015 to help with the transition.